BiotechTubeBiotechTube
Home/CKP Therapeutics/Chan Wung Kim
CW

Chan Wung Kim

co-CEO

CKP Therapeutics

Therapeutic Areas

OncologySolid Tumors

CKP Therapeutics Pipeline

DrugIndicationPhase
C7Drug-Resistant Papillary Thyroid CarcinomaPre-clinical
C13Drug-Resistant Papillary Thyroid CarcinomaPre-clinical
C19Drug-Resistant Hepatocellular CarcinomaPre-clinical
C23Drug-Resistant Hepatocellular CarcinomaPre-clinical

Leadership Team at CKP Therapeutics

JH
Jae Ha Lee
co-CEO
RT
Raymond T. Weicker
CFO & Legal Counsel
KC
Ki Cheong Park
Chief Scientific Officer
SK
Seok-Mo Kim
Chief Medical Officer
KH
Kyung Hwa Choi
Chief Research Officer
View full CKP Therapeutics profile